发明公开
EP1687257A2 AMINO-SUBSTITUTED ETHYLAMINO &Bgr;2 ADRENERGIC RECEPTOR AGONISTS
有权
氨基ETHYLAMINOAGONISTEN 2-肾上腺素能受体
- 专利标题： AMINO-SUBSTITUTED ETHYLAMINO &Bgr;2 ADRENERGIC RECEPTOR AGONISTS
- 专利标题（中）： 氨基ETHYLAMINOAGONISTEN 2-肾上腺素能受体
-
申请号： EP04784634.0申请日： 2004-09-21
-
公开(公告)号： EP1687257A2公开(公告)日： 2006-08-09
- 发明人: LINSELL, Martin, S. , JACOBSEN, John, R. , SAITO, Daisuke, Roland
- 申请人： Theravance, Inc.
- 申请人地址： 901 Gateway Boulevard South San Francisco, CA 94080 US
- 专利权人： Theravance, Inc.
- 当前专利权人： Theravance, Inc.
- 当前专利权人地址： 901 Gateway Boulevard South San Francisco, CA 94080 US
- 代理机构： Scott, Susan Margaret
- 优先权： US505685P 20030922
- 国际公布： WO2005030678 20050407
- 主分类号： C07C233/43
- IPC分类号： C07C233/43 ; C07D215/24 ; A61K31/167 ; A61K31/4704 ; A61P11/08
摘要：
The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
公开/授权文献
信息查询
